AW Technologies and Asahi Kasei Medical, a core operating company of the Japanese technology company Asahi Kasei, have entered into an exclusive distribution agreement in Japan for AW Technologies’ TrachFlush device. AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024.

Developed by AW Technologies based on an invention by an intensivist, the TrachFlush is a medical device to reduce the discomfort of ventilated patients while lightening the workload on healthcare professionals during tracheal suctioning.

The TrachFlush supports airway secretion (phlegm) management with a unique cuff pressure control system. With the push of a button, the TrachFlush deflates the cuff and utilizes the ventilator air pressure during an inspiratory cycle and re-inflates the cuff before the cycle completes.

TrachFlush has received the CE Mark in Europe in 2020 and FDA clearance in the United States in 2023. In Japan, marketing and sale is to be performed by Asahi Kasei Medical.